Cooley advised AN2 Therapeutics, Inc., and Davis Polk & Wardwell advised the joint book-running managers on the offering. AN2 Therapeutics, Inc. (Nasdaq:ANTX) announced a SEC-registered follow-on...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Energy Transfer LP and Vinson & Elkins advised Crestwood Equity Partners LP on the transaction. Bracewell represented Evercore as financial advisor to...
You must be a Standard 1 Year member to access this content.
Cooley advised Gracell Biotechnologies; and Davis Polk & Wardwell advised the placement agents on the deal. Gracell Biotechnologies Inc. (Nasdaq: GRCL) announced that it has entered into a...
You must be a Standard 1 Year member to access this content.
Gibson Dunn advised GE HealthCare Technologies, Paul, Weiss advised General Electric, and Simpson Thacher advised the representatives of the underwriters. Simpson Thacher also represented Morgan Stanley...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers in the offering. Editas Medicine, Inc. (Nasdaq: EDIT) announced the pricing of an underwritten offering of 12,500,000 shares of its...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell LLP advised Mobileye Global Inc on the offering, while Sullivan & Cromwell LLP advised the underwriters. Mobileye Global Inc., a leader of the...
You must be a Standard 1 Year member to access this content.
Simpson Thacher represented Gates Industrial Corporation plc on the offering, while Davis Polk advised Citigroup Global Markets Inc., Evercore Group L.L.C. and Goldman Sachs & Co....
You must be a Standard 1 Year member to access this content.
Freshfields Bruckhaus advised EVgo, and Latham & Watkins advised the underwriters. EVgo Inc. announced the pricing on May 17, 2023 of an underwritten public offering of 29,411,765...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the sales agents, RBC Capital Markets, LLC and Evercore Group L.L.C., on the transaction. Emergent BioSolutions Inc., an American multinational specialty biopharmaceutical company headquartered in...
You must be a Standard 1 Year member to access this content.
Cooley advises Vaxcyte on the offering, and Latham & Watkins advises the underwriters. Vaxcyte, Inc. (Nasdaq: PCVX) has announced the pricing of an underwritten public offering...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised BridgeBio Pharma on the offering, and Latham & Watkins advised the underwriters involved. BridgeBio Pharma, Inc. announced the pricing on March 7, 2023 of...
You must be a Standard 1 Year member to access this content.
Cooley advised Longboard Pharmaceuticals on the offering, and Latham & Watkins advised the underwriters involved. Longboard Pharmaceuticals, Inc. announced the pricing of its previously announced underwritten public...
You must be a Standard 1 Year member to access this content.
